Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device

Core Insights - Movano Health has initiated a clinical trial for its new cuffless blood pressure wrist wearable, aiming to enhance signal fidelity and monitor various vital signs [1][2] - The trial will involve at least 70 participants and is expected to be completed by mid-February 2025, comparing the new device's data with that from a hospital-grade blood pressure device [1][2] - The company has previously conducted three clinical trials in late 2024 and 2023, gathering data from over 60 participants to refine its technology [2] Company Overview - Movano Health, founded in 2018, focuses on developing healthcare solutions that provide medical-grade data through innovative wearable devices [3] - The company's products aim to deliver comprehensive health data and personalized insights to users, enhancing proactive health management [3][4] - Movano Health is committed to advancing its proprietary technologies to improve health outcomes across diverse patient populations [4]